C-4 modified sialosides enhance binding to Siglec-2 (CD22): towards potent Siglec inhibitors for immunoglycotherapy (Q86204254)
Jump to navigation
Jump to search
scientific article published on 25 February 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | C-4 modified sialosides enhance binding to Siglec-2 (CD22): towards potent Siglec inhibitors for immunoglycotherapy |
scientific article published on 25 February 2013 |
Statements
C-4 modified sialosides enhance binding to Siglec-2 (CD22): towards potent Siglec inhibitors for immunoglycotherapy (English)
Paul Madge
Tasneem Islam
Ryan Bennett
Hendrik Koliwer-Brandl
Mario Waespy
Mark von Itzstein
25 February 2013